ArticleJournal of translational internal medicine2025
The plakin family: Potential therapeutic targets for digestive system tumors.
Article in Journal of translational internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digestive system tumors remain a global health challenge; however, the mechanisms underlying their tumorigenesis remain unclear. Identifying these mechanisms may facilitate early detection and more effective treatment. Members of the plakin family play crucial roles in cytoskeletal integrity and cell adhesion. Moreover, they regulate key cellular processes implicated in tumor development, including tumor cell migration, proliferation, and signaling. Therefore, exploring the potential roles of the plakin family members in digestive system tumors has attracted increasing attention. In this review, we provide a comprehensive examination of the biological characteristics of the plakin family members and an in-depth analysis of their clinicopathological significance and clinical implications in digestive system tumors. In summary, the plakin family is a translationally valuable diagnostic marker and a potential therapeutic target for digestive system tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.